Veeva Systems (NYSE:VEEV) is scheduled to announce its earnings results after the market closes on Tuesday, November 26th. Analysts expect the company to announce earnings of $0.41 per share for the quarter. Veeva Systems has set its Q3 guidance at $0.54-0.55 EPS and its FY20 guidance at $2.11-2.13 EPS.Investors that wish to register for the company’s conference call can do so using this link.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Tuesday, August 27th. The technology company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.03. Veeva Systems had a return on equity of 18.10% and a net margin of 29.72%. The company had revenue of $266.90 million for the quarter, compared to analysts’ expectations of $259.35 million. During the same period last year, the business earned $0.39 EPS. Veeva Systems’s quarterly revenue was up 27.3% compared to the same quarter last year. On average, analysts expect Veeva Systems to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Shares of VEEV opened at $151.76 on Tuesday. Veeva Systems has a 12-month low of $79.26 and a 12-month high of $176.90. The business’s fifty day moving average is $147.93 and its 200 day moving average is $154.92. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.01. The stock has a market cap of $22.00 billion, a P/E ratio of 122.39, a P/E/G ratio of 4.83 and a beta of 1.26.

A number of equities analysts recently issued reports on VEEV shares. KeyCorp increased their target price on Veeva Systems from $172.00 to $190.00 and gave the stock an “overweight” rating in a report on Wednesday, August 28th. Stifel Nicolaus increased their target price on Veeva Systems from $155.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, August 23rd. Stephens increased their target price on Veeva Systems from $155.00 to $185.00 and gave the stock an “overweight” rating in a report on Wednesday, August 28th. Raymond James upgraded Veeva Systems from a “market perform” rating to an “outperform” rating and set a $180.00 target price on the stock in a report on Thursday, September 26th. Finally, JMP Securities increased their target price on Veeva Systems from $153.00 to $172.00 and gave the stock a “market outperform” rating in a report on Wednesday, August 28th. Eight analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Veeva Systems currently has a consensus rating of “Buy” and an average price target of $168.11.

In other Veeva Systems news, CAO Michele O’connor sold 1,600 shares of the firm’s stock in a transaction on Friday, October 4th. The stock was sold at an average price of $151.94, for a total transaction of $243,104.00. Following the transaction, the chief accounting officer now directly owns 1,817 shares in the company, valued at approximately $276,074.98. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Timothy S. Cabral sold 15,000 shares of the firm’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $167.57, for a total value of $2,513,550.00. Following the transaction, the chief financial officer now owns 586 shares in the company, valued at $98,196.02. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 75,506 shares of company stock worth $11,755,615. Company insiders own 14.38% of the company’s stock.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, data solutions, and master data management solutions; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety.

Featured Article: What is diluted earnings per share (Diluted EPS)?

Earnings History for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.